# A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants

> **NCT02541669** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 64 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** TAK-491
- **DRUG:** TAK-491 placebo

## Key facts

- **NCT ID:** NCT02541669
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-20
- **Primary completion:** 2017-03-17
- **Final completion:** 2017-03-17
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02541669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02541669, "A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02541669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*